The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Biomarkers Market In 2026 And 2030?
The biomarkers market has experienced substantial expansion in recent years. It is projected to grow from $77.42 billion in 2025 to $88.42 billion in 2026, with a compound annual growth rate (CAGR) of 14.2%. This historic growth can be attributed to advancements in molecular biology, increasing pharmaceutical research and development spending, a rise in cancer prevalence, expanded use in clinical trials, and the demand for targeted therapies.
The biomarkers market is set for substantial growth over the next few years, with projections indicating it will reach $150.52 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.2%. This expansion during the forecast period is attributed to the increasing adoption of personalized treatment approaches, the rising use of liquid biopsy biomarkers, stronger regulatory backing for biomarker-based drugs, a surge in neurological disease research, and growing collaborations between pharmaceutical and diagnostics companies. Key trends anticipated in this period include the wider application of biomarkers in precision medicine, their deeper incorporation into drug discovery and development, increasing utilization in oncology and chronic disease management, the proliferation of companion diagnostics, and a heightened emphasis on early disease detection.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp
What Key Drivers Are Fueling The Growth Of The Biomarkers Market?
The escalating prevalence of heart diseases is projected to stimulate the growth of the biomarkers market during the forecast period. There has been a remarkable rise in the application of biomarkers for individuals suffering from heart conditions over recent years. Presently, natriuretic peptides stand as the most commonly employed biomarkers, instrumental in diagnosing patients with heart failure. Additionally, biomarkers like circulating biomarkers combined with high sensitivity C-reactive protein are utilized for heart failure diagnosis. Heart disease is identified as a leading cause of death for most racial and ethnic groups within the United States. Consequently, the rising incidence of heart diseases is set to boost the demand for biomarkers. A case in point is the data from September 2025 by the British Heart Foundation, a UK-based charity, indicating that over 7.6 million people across the UK—including more than 4 million men and more than 3.6 million women—are living with cardiovascular disease. Projections further suggest that this figure may climb by approximately 1 million by 2030 and by about 2 million by 2040, attributed to an aging population and enhanced survival rates. Therefore, the expanding burden of heart diseases is indeed fueling the expansion of the biomarkers market.
How Is The Biomarkers Market Categorized Across Its Segment Groups?
The biomarkers market covered in this report is segmented –
1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
3) By Type: Biomarker Of Exposure, Biomarker Of Diseases
4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies
Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers
2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers
3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers
What Market Trends Are Affecting The Biomarkers Market?
Companies operating in the biomarker market are actively innovating, developing products like biomarker tests to reach larger customer populations, boost sales, and increase revenue. Biomarker tests, also referred to as biomarker assays, are laboratory or diagnostic procedures that measure particular biological markers, which can include molecules, genes, proteins, or other substances, providing information about diverse physiological or pathological processes in the body. For example, in July 2023, Quest Diagnostics, a US-based medical laboratories company, introduced a new prostate cancer biomarker test. This newly unveiled tissue-based test service aims to fulfill the urgent clinical need for tests that can help differentiate potentially aggressive prostate cancer cases in males. Quest developed and validated this laboratory test through an intellectual property license agreement with Envision, allowing the use of Envision’s exclusive biomarker and immunohistochemistry technology, which integrates Envision’s distinct staining methods and innovative biomarkers known as EV1, EV2, and EV3.
Which Firms Are Influencing Competition In The Biomarkers Market?
Major companies operating in the biomarkers market are Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.
Get The Full Biomarkers Market Report:
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Which Region Holds The Highest Market Share In The Biomarkers Market?
North America was the largest region in the biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Biomarkers Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Browse Through More Reports Similar to the Global Biomarkers Market 2026, By The Business Research Company
Biomarkers Market Report 2026
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Clinical Biomarkers Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report
Cancer Biomarker Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model